Breast Biopsy Market Set To Reach worth $728.8 Million by 2020

01/mar/2016 07:56:32 MarketsandMarkets Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.
The report “Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), by Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020”, The global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020.
Browse 75 market data tables and 66 figures spread through 152 pages and in-depth TOC on “Breast Biopsy Market"
Early buyers will receive 10% customization on this report.
On the basis of type, the market is classified into needle and open surgical breast biopsy. The needle breast biopsy segment is expected to account for the largest share of the market, because of the increased preferences for needle biopsies over open surgical breast biopsies and the demand for scar-less and painless surgical procedures.
The market is segmented on the basis of product, type, guidance, and region. The breast biopsy guidance market is categorized into mammography, ultrasound, MRI, and others (PET and thermography). In this market, the ultrasound segment is expected to be the fastest-growing segment owing to the increasing demand for minimally invasive and non-radiation breast biopsy among patients and surgeons.
Talk To Our Research Analysts:
On the basis of product, the market is classified into biopsy needles, guidance systems, biopsy tables, localization wires, and others (markers, punches, sutures). The growth of the segment can be attributed to the increasing demand for needle biopsies such as core-needle and vacuum-assisted biopsy globally.
Geographically, the market is dominated by North America, followed by Europe. The market in Asia-Pacific is expected to grow at the highest CAGR during the forecast period. Its high growth can be attributed to the rise in the purchasing power of the middle class and increasing awareness about breast cancer screening.
Major factors fueling market growth are the rising incidences of breast cancer among women and increase in breast cancer screening programs in different countries. In addition to this, the increase in reimbursement rates in U.S. for image-guided biopsy and the growing demand for less-invasive breast biopsy are propelling the growth of the market.
Get The Sample Pages:
Key players operating in the breast biopsy market are Becton, Dickinson and Company (U.S.), C.R. Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), and Hologic Inc. (U.S.).
About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Mr. Rohan
Unit No. 802, 8th Floor, 
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013, 
Maharashtra, India.
Tel: +1-888-6006-441.
Get your own FREE website, FREE domain & FREE mobile app with Company email.  
Know More >
blog comments powered by Disqus è un servizio offerto da Factotum Srl